We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hong Kong Drugmaker Warned for Quality Control, Procedural Shortcomings
Hong Kong Drugmaker Warned for Quality Control, Procedural Shortcomings
Wong Lap Kwong Medicine Company drew a warning from the FDA for failing to identify active pharmaceutical ingredients and to establish procedures for numerous basic functions in its Hong Kong facility.